Lexicon Pharmaceuticals, Inc.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $10.7M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $81.2M |
| SG&A Expense | $19.4M |
| Operating Income | $-90.0M |
| Operating Margin | -840.7% |
| Interest Expense | $3.0M |
| Pretax Income | $-93.4M |
| Income Tax Expense | $-102.0K |
| Net Income | $-82.8M |
| Net Margin | -773.6% |
| EPS (Basic) | $-0.57 |
| EPS (Diluted) | $-0.57 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |